| 标题 |
PRESERVE 2: A randomized, phase 3, double-blind trial of trilaciclib or placebo in patients (pts) receiving first-line gemcitabine/carboplatin (GCb) for locally advanced or metastatic triple-negative breast cancer (mTNBC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:Shom Goel; Joyce O’Shaughnessy; Binghe Xu; Zhongsheng Tong; Shusen Wang; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)